Tiffany, Kors to Re...
Health Care: Health Services
Ironwood Pharmaceuticals Inc. (IRWD: NASDAQ)
$12.80 0.28 | 2.27%
05/24/13 - 02:40 PM ET
Portfolios with IRWD
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorStocks With Big Insider Buy...
- ContributorDrugs Facing FDA Approval i...
- ContributorStocks Rising On Unusual Vo...
- Contributor10 Pharma Stocks With Upside
- ProBridger Management
- ContributorRocket Stocks for the Week ...
- ContributorBarron's Insider Purchases ...
Latest IRWD Headlines from TheStreet
- Top Insider Trades: ATVI, SCS, KSS, IRWD 04.03.13 | 07:04 am
- Analysts' Actions: FCX IRWD RIG SCHW ULTA 03.15.13 | 08:03 am
- Cramer's 'Mad Money' Recap: The Bullish Facts 01.17.13 | 08:01 pm
- Ironwood Pharmaceuticals Inc. Stock Downgraded (IRWD) 01.17.13 | 04:01 am
- Analysts' Actions: AAPL DELL IRWD K SEE FB 01.16.13 | 08:01 am
- 5 Stocks Set to Soar on Bullish Earnings 01.14.13 | 12:01 pm
- 5 Stocks With Big Insider Buying 11.07.12 | 12:11 pm
- Ironwood Pharmaceuticals Inc. Stock Upgraded (IRWD) 10.18.12 | 05:10 am
- Insiders Trading WPP LAMR DW IRWD 09.26.12 | 10:09 am
- 31 Drugs Facing FDA Approval in 2012-2013 08.20.12 | 08:08 am
Press Releases for IRWD
- Edward Owens, Ironwood Board Of Directors (Photo: Business Wire) - Business Wire 03.04.13 | 08:03 am
- Ironwood Pharmaceuticals To Present At Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.25.13 | 04:02 pm
- Mark Currie, Ph.D., Senior Vice President, CSO, And President Of R&D Of Ironwood Pharmaceuticals, Inc. (Photo: Business Wire) - Business Wire 02.11.13 | 09:02 am
- Ironwood Pharmaceuticals Provides Fourth Quarter 2012 Investor Update - Business Wire 01.15.13 | 07:01 am
- Ironwood Pharmaceuticals To Host Fourth Quarter 2012 Investor Update Call - Business Wire 01.10.13 | 04:01 pm
- Ironwood Completes $175 Million Debt Offering - Business Wire 01.04.13 | 10:01 am
- Ironwood Pharmaceuticals To Present At J.P. Morgan Healthcare Conference - Business Wire 01.02.13 | 04:01 pm
- FACT SHEET -- Chronic Idiopathic Constipation - Business Wire 12.17.12 | 08:12 am
- Protagonist And Ironwood Expand Peptide Drug Discovery Collaboration - Business Wire 12.06.12 | 08:12 am
- Constella® (linaclotide) Approved In Europe For The Treatment Of Irritable Bowel Syndrome With Constipation (IBS-C)in Adults - PR Newswire 11.28.12 | 10:11 am
Partner Headlines for IRWD
- EU Approval for Ironwood's Constella - Analyst Blog - Zacks 11.30.12 | 02:11 pm
- Earnings Scorecard: Forest Labs - Analyst Blog - Zacks 10.26.12 | 06:10 pm
- Ironwood and AstraZeneca Announce Linaclotide Collaboration for China - Benzinga 10.23.12 | 09:10 am
- FDA OK's Forest-Ironwood's Linzess - Analyst Blog - NASDAQ 08.31.12 | 09:08 pm
- FDA OK's Forest-Ironwood's Linzess - Analyst Blog - Zacks 08.31.12 | 05:08 pm
- Hedging Ironwood before ruling - NASDAQ 08.28.12 | 09:08 am
- Ironwood Pharmaceuticals, Earnings Call INSIGHTS: Huge Opportunity in CC, Feeling Good About Commercial Readiness - Wall St. Cheat Sheet 07.18.12 | 11:07 am
- Delay in Forest Drug FDA Action Date - Analyst Blog - Zacks 03.30.12 | 05:03 pm
- Forest-Janssen Sue Generic Players - Analyst Blog - Zacks 03.16.12 | 07:03 pm
- Teva Launches Generic Lexapro - Analyst Blog - Zacks 03.15.12 | 09:03 am
